期刊文献+

微量白蛋白尿与代谢综合征及其组分的关系 被引量:1

Prevalence of microalbuminuria and its association with metabolic syndrome in general population
下载PDF
导出
摘要 目的筛查普通人群微量白蛋白尿(MAU)的患病率,并分析代谢综合征(MS)不同组分与MAU的关系。方法对进行体检的1654例健康人群测定身高、体重、血压、空腹血糖、血脂、尿微量白蛋白和肌酐等指标,分组统计MAU的患病率及与MS各组分的关系。结果MAU组年龄、体重指数、血压、空腹血糖和血脂水平均显著高于无MAU组。MAU在普通人群中的患病率为8.1%,随着年龄的增长,MAU的患病率有增高的趋势,60岁以后显著增高。各代谢异常组MAU的患病率显著增高,以MS组患病率最高,达20.7%。肥胖、高血压、高血糖、血脂紊乱和年龄是MAU发生的独立风险因素,御值分别为3.11、2.99、2.54、1.62、1.22。结论肥胖、高血压、高血糖、血脂紊乱和年龄是MAU发生的主要风险因素,对中老年人和代谢异常人群进行MAU的筛查是必要的。 Objective To investigate the prevalence of microalbuminuria (MAU) and its association with metabolic syn-drome (MS) in general population. Methods A total 1 654 subjects undergoing health check-up in Hangzhou city were selected by multistage,clustered complex sampling method. The fasting glucose, blood lipids, urinary albumin, urinary creatinine and an-thropometric indices were measured. The association of MAU with MS and its components were examined by univariate and multivariate logistic regression analysis. Results Subjects with MAU had higher age, BMI, blood pressure, fasting glucose and triglycerides levels than those without MAU. The prevalence of MAU in this population was 8.1%. The incidence of MAU was in- creased with the age. The prevalence of MAU increased in subjects with metabolic abnormalities and for those with metabolic syndrome the incidence of MAU was 20.7%. Obesity, hypertension, hyperglycemia, hyperlipidemia and age were independent risk factors for MAU in both genders, the odds ratios were 3.11, 2.99, 2.54, 1.62 and 1.22, respectively, Conclusion Obesity, high blood pressure, high blood lipids, high blood sugar and age are main risk factors causing MAU in general population.
出处 《浙江医学》 CAS 2011年第12期1753-1755,1798,共4页 Zhejiang Medical Journal
关键词 微量白蛋白尿 普通人群 患病率 代谢综合征 Microalbuminuria General population Prevalence Metabolic syndrome
  • 相关文献

参考文献12

  • 1Kraus G, Geffin R, Spruill G, et al. Cross-clade inhibition of HIV-1 replication and cytopathology by using RNase P-associated external guide sequences. Proc Natl Acad Sci U S A, 2002,19 :3406-3411. 被引量:2
  • 2Trang P, Lee J, Kilani AF, et al. Effective inhibition of herpes simplex virus 1 gene expression and growth by engineered RNase P ribozyme. Nucleic Acids Res, 2001, 29 : 5071-5078. 被引量:2
  • 3Zhou T, Kim J, Kilani AF, et al. In vitro selection of external guide sequences for directing RNase P-mediated inhibition of viral gene expression. J Biol Chem, 2002, 277:30112-30120. 被引量:2
  • 4卢艳慧,陆菊明,王淑玉,李春霖,刘力生,郑润平,田慧,王先令,杨丽娟,张育青,潘长玉.国际糖尿病联盟与中国糖尿病学会关于代谢综合征诊断标准的比较分析[J].中华医学杂志,2006,86(6):386-389. 被引量:79
  • 5Menno T.Prevalence of microalbuminuria in the general populat ion of Seychelles and strong association with diabetes and hypertension independent of renal markers[J].Journal of Hypertension,2008,26:871-877. 被引量:1
  • 6Kuwabara T, Warashina M, Tanabe T, et al. A novel allosteric trans-activated ribozyme, the maxizyme, with exceptional specificity in vitro. Mol Cell, 1998, 2: 617-627. 被引量:2
  • 7Cobaleda C, Sanchez-Garcia I. RNase P: from biological function to biotechnological applications. Trends Biotechnol, 2001, 19:406-411. 被引量:2
  • 8李青,贾伟平,陆俊茜,陈蕾,吴元民,姜素英,项坤三.上海市两社区人群微量白蛋白尿患病率与代谢综合征各组分的关系[J].中华流行病学杂志,2004,25(1):65-68. 被引量:22
  • 9Diekmann D, Brill S, Garrett MD, et al. Bcr encodes a GTPaseactivating protein for p21rac. Nature, 1991, 351: 400-402. 被引量:2
  • 10Jahagirdar BN, Miller JS, Shet A, et al. Novel therapies for chronic myelogenous leukemia. Exp Hematol, 2001, 29: 543-556. 被引量:2

二级参考文献36

  • 1中华医学会糖尿病学分会代谢综合征研究协作组.中华医学会糖尿病学分会关于代谢综合征的建议[J].中国糖尿病杂志,2004,12(3):156-161. 被引量:3063
  • 2Mykkanen L, Zaccaro D J, Wagenknecht LE, et al.Microalbuminuria is associated with insulin resistance in nondiabetic subjects: The Insulin Resistance Atherosclerosis Study. Diabetes,1998, 47 : 793-800. 被引量:1
  • 3Hoy WE, Mathews JD, McCredie DA, et al. The multidimensional nature of renal disease: rates and a.ssiociations of albuminuria in an Australian Aboriginal community. Kidney Ira, 1998, 54 : 1296-1304. 被引量:1
  • 4Jager A, Kostense PJ, Nijpels G, et al. Microalbuminuria is strongly associated with NIDDM and hypertension, but not with the insulin resistance syndrome: the Hoom Study. Diabetologia,1998,41 : 694-700. 被引量:1
  • 5Bakris GL. Microalbuminuria: what is it? why is it important?what should be done about it? J Clin Hypertens, 2001,3 : 99-102. 被引量:1
  • 6Kim YI, Kim CH, Choi CS, et al. Microalbuminuria is associated with the insulin resistance syndrome independent of hypertension and type 2 diabetes in the Korean population. Diabetes Research and Clinical Practice, 2001,52 : 145-152. 被引量:1
  • 7World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation, Part 1: Diagnosis and classification of diabetes mellitus. WHO: Geneva, 1999. 被引量:1
  • 81999 World Health Organization-international society of hypertension guidelines for the management of hypertension.Guideline subcommittee. J Hypertens, 1999,17 : 151-183. 被引量:1
  • 9Rowley KG, Iser DM, Best JD, et al. Albuminuria in Australian Aboriginal people: prevalence and asscioations with components of the metabolic syndrome. Diabetologia,2000,43:1397-1403. 被引量:1
  • 10Hotamisligil GS, Amer P, Cam JF, et al. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin-resistance. J Clin Invest, 1995,95:2409-2415. 被引量:1

共引文献109

同被引文献1

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部